Prot# SILCAAT: A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (the "SILCAAT Trial")
- Murphy, Robert Leo (PD/PI)
Project: Research project